Developing systems for transporting blood to and throughout the battlefield
MaxQ Research has been awarded a Phase I SBIR contract from the United States Defense Health Agency (DHA) SBIR/STTR Program.
Throughout this 6 month effort, with technical oversight under the US Army Institute of Surgical Research (USAISR), MaxQ Research will work to help address the challenges faced by the U.S. Armed Services Blood Program (ASBP).
“We are committed to developing a core technology that could have a major impact to both civilian and military emergency medicine, our team is focused on delivering a solution that could potentially maximize the useable life of life saving vaccines, pharmaceuticals and blood products.”
Dr. Arif Rahman, Director of Research, MaxQ
MaxQ will lead the effort towards the development (design, fabrication and testing) of a low- or no-power advanced transportation container technology for the transportation and storage of blood and blood products at or near the battlefront. Traumatic hemorrhage remains the leading cause of combat deaths. Timely and balanced resuscitation with blood components leads to increased survival by achieving hemostasis as quickly as possible. However, transporting and maintaining blood inventory at far forward bases can be challenging. At each step, temperature control is critical if blood is to remain in compliance with established standards; very little variance is allowed. Thus, along with the capability of maintaining these temperatures, a careful record demonstrating the unbroken cold chain is required.
MaxQ aims to demonstrate the technical feasibility of its MaxPlus intelligent temperature control (ITC) system architecture that could be standardized access different legs of the military blood supply chain. With an integrated temperature monitoring system, it would provide real-time thermodynamic energy status and predictive analytics to minimize the risk of temperature excursion for any long duration blood product transportation.
About ISR: The US. Army Institute of Surgical Research (USAISR) Blood Coagulation Research Department, maintains a comprehensive program to provide tools and means of reducing combat casualty death due to hemorrhage. A major goal of these efforts is improvement of availability of blood products and optimization of delivery of blood to combat casualties.
About DHA: The Defense Health Agency (DHA) is a joint, integrated Combat Support Agency that enables the Army, Navy, and Air Force medical services to provide a medically ready force to Combatant Commands in both peacetime and wartime.
About MaxQ: Trusted by over 700 hospitals, Grifols, Blood Centers of America and clinical trial teams across the globe, MaxQ’s mission is to help your clients protect the safety of patients. Our packaging systems meet strict requirements to help make sure your product is protected, maintaining the quality of temperature-sensitive products. The result is a safer product with almost zero risk of product loss, thereby leading to a cost and performance-optimized supply chain. We are the most comprehensive solution provider for blood and blood based biologics packaging and transport covering every leg of the supply chain.
For questions, please contact Saravan Kumar, CEO, at saravank@flymaxq.com.
